Consistent with the above, in MSCs of primary osteoporosis we also observed the enhanced expression of GREM1 and GREM2, the only two antagonist genes found to be commonly up-regulated by SMAD signaling in this study (Figs. 4 and 5). This evidence concerns the gene GREM2 and osteoporosis.